A first-in-human trial is being conducted to test the use of exosomes targeting a specific mutation in pancreatic cancer. The trial, which involves engineered exosomes with siRNA, is a phase I study that aims to explore its effects on the disease. Research on the biology and function of exosomes is also being applied to their potential biomedical applications, including cancer treatment.